IL1B and ovarian cancer: Since there was a significant Spearman correlation between serum and urinary IL-1β levels in ovarian benign disorders (r = 0.949, N = 4, p = 0.051) and in ovarian cancers (r = 0.724, N = 11, p = 0.012), and there was a very limited number of available serum samples, all remaining clinical comparisons were completed in urine samples only.